Intravenous Single-dose Toxicity of Mountain Ginseng Pharmacopuncture in Sprague-Dawley Rats
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: Mountain ginseng pharmacopuncture (MGP) is an extract distilled from either mountain cultivated ginseng or mountain wild ginseng. This is the first intravenous injection of pharmacopuncture in Korea. The word intravenous does not discriminate between arteries, veins, and capillaries in Oriental Medicine, but only the vein is used for MGP. The aim of this study is to evaluate the intravenous injection toxicity of MGP through a single-dose test in Sprague-Dawley (SD) rats. Methods: Male and female 6-week-old SD rats were injected intravenously with MGP (high dosage of 20 mL/kg or low dosage of 10 mL/kg). Normal saline was injected into the rats in the control group by using the same method. After the rats has treated, we conducted clinical observations, body-weight measurements and histological observations. Results: In this study, no mortalities were observed in any of the experimental groups. Also, no significant changes by the intravenous injection of MGP were observed in the body weights, or the histological observations in any of the experimental groups compared to the control group. The lethal dose for intravenous injection of MGP was found to be over 20 mL/kg in SD rats. Conclusion: Considering that the dosage of MGP generally used each time in clinical practice is about 0.3 mL/kg, we concluded with confidence that MGP is safe pharmacopuncture.
Abstract
Objectives: Mountain ginseng pharmacopuncture (MGP) is an extract distilled from either mountain cultivated ginseng or mountain wild ginseng. This is the first intravenous injection of pharmacopuncture in Korea. The word intravenous does not discriminate between arteries, veins, and capillaries in Oriental Medicine, but only the vein is used for MGP. The aim of this study is to evaluate the intravenous injection toxicity of MGP through a single-dose test in Sprague-Dawley (SD) rats. Methods: Male and female 6-week-old SD rats were injected intravenously with MGP (high dosage of 20 mL/kg or low dosage of 10 mL/kg). Normal saline was injected into the rats in the control group by using the same method. After the rats has treated, we conducted clinical observations, body-weight measurements and histological observations. Results: In this study, no mortalities were observed in any of the experimental groups. Also, no significant changes by the intravenous injection of MGP were observed in the body weights, or the histological observations in any of the experimental groups compared to the control group. The lethal dose for intravenous injection of MGP was found to be over 20 mL/kg in SD rats. Conclusion: Considering that the dosage of MGP generally used each time in clinical practice is about 0.3 mL/kg, we concluded with confidence that MGP is safe pharmacopuncture.
참고문헌 (41)
- Korean Pharmacopuncture Institute, "Pharmacopuncturology", pp.191~197 (2012), Elsevier Korea
- Kwon Ki-Rok, "산삼(山蔘)에 대한 문헌적(文獻的) 고찰(考察)", Journal of Pharmacopuncture, 6(2), pp.67~75 (2003), 대한약침학회[DOI]
- 이광호, "Identification and Analysis of the Chloroplast rpoC1 Gene Differentially Expressed in Wild Ginseng", Journal of Pharmacopuncture, 15(2), pp.20~23 (2012), 대한약침학회[DOI]
- 한영주, "Identification and Analysis of the Novel pGAPDH-w Gene Differentially Expressed in Wild Ginseng", Journal of Pharmacopuncture, 16(1), pp.30~36 (2013), 대한약침학회[DOI]
- 권기록, "Identification and Analysis of Differentially Expressed Genes in Mountain Cultivated Ginseng and Mountain Wild Ginseng", Journal of Acupuncture & Meridian Studies, 4(2), pp.123~128 (2011), 사단법인약침학회
- 김두영, "Identification and Expression Analysis of Chloroplast p-psbB Gene Differentially Expressed in Wild Ginseng", Journal of Pharmacopuncture, 15(1), pp.18~22 (2012), 대한약침학회[DOI]
- 권기록, "Anticancer effect of mountain ginseng Pharmacopuncture to the nude mouse of lung carcinoma induced by NCI-H460 human non-small cell lung cancer cells", Journal of Pharmacopuncture, 13(1), pp.5~14 (2010), 대한약침학회
- M S Bartlett., "Properties of sufficiency and statistical test", Pros. R. Soc. Lond. A., 160 (1937)
- C W., "Dunnett. New tables for multiple comparisons with control", Biometrics, 20(3), pp.482~491 (1964)
- 이종영, "血脈에 대한 문헌적 고찰", Journal of Pharmacopuncture, 8(3), pp.11~19 (2005), 대한약침학회
- 강미숙, "≪黃帝內經․靈樞≫를 통한 血脈小考", 대한침구의학회지, 27(6), pp.111~114 (2010), 대한침구의학회
- Kwon Ki-Rok, "A Clinical Study on the Effects of Intravenous Wild ginseng Herbal Acupuncture on the Human Body", Journal of Pharmacopuncture, 7(1), pp.15~26 (2004), 대한약침학회[DOI]
- 권기록, "자연산 산삼 증류약침의 혈맥주입 전·후 혈장의 proteom분석", Journal of Pharmacopuncture, 7(3), pp.5~25 (2004), 대한약침학회
- 이동희, "산양산삼 증류약침의 혈맥주입 후 나타나는 혈장의 Proteom 분석", Journal of Pharmacopuncture, 9(2), pp.17~37 (2006), 대한약침학회
- 노정두, "산삼 약침이 정상인의 심박변이도(HRV)에 미치는 영향", Journal of Pharmacopuncture, 11(1), pp.55~69 (2008), 대한약침학회
- 박상욱, "산삼 약침이 정상 중년여성의 맥파요인에 미치는 영향", Journal of Pharmacopuncture, 14(1), pp.35~50 (2011), 대한약침학회
- 김영진, "산삼약침의 간 기능 개선효과에 대한 증례보고", Journal of Pharmacopuncture, 12(2), pp.107~112 (2009), 대한약침학회
- 김영진, "인삼, 한국 및 중국산 산양삼의 간 보호 효능에 관한 실험적 연구", Journal of Pharmacopuncture, 10(1), pp.101~107 (2007), 대한약침학회
- 최은주, "산양산삼약침의 지질강하 및 항산화효과에 대한 생화학적 및 분자생물학적 검토", Journal of Pharmacopuncture, 9(1), pp.5~20 (2006), 대한약침학회
- 안영민, "산삼과 산양삼 추출물의 항암 및 항산화 효능", Journal of Pharmacopuncture, 10(1), pp.5~16 (2007), 대한약침학회
- 김형석, "HepG2세포의 산화적 손상에 대한 산삼 추출물의 보호효과 -DAN chip을 이용하여-", Journal of Pharmacopuncture, 10(1), pp.121~135 (2007), 대한약침학회
- 장해영, "자연산 산삼, 산양삼 및 인삼의 항산화능 비교연구", Journal of Pharmacopuncture, 11(3), pp.67~78 (2008), 대한약침학회
- 임태진, "인삼 및 산양삼의 항산화 효능 비교 -Superoxide radical과 Hydroxy radical 소거활성을 중심으로-", Journal of Pharmacopuncture, 12(2), pp.7~12 (2009), 대한약침학회
- 권기록, "The Study on Acute and Subacute Toxicity and Anti-Cancer Effects of cultivated wild ginseng Herbal acupuncture", Journal of Pharmacopuncture, 6(2), pp.7~27 (2003), 대한약침학회[DOI]
- Cho Hee-Chul, "An Experimental Study on Apoptosis of cultivated Wild Ginseng Distilled Herbal Acupuncture by Concentration Level", Journal of Pharmacopuncture, 7(2), pp.5~17 (2004), 대한약침학회[DOI]
- 권기록, "B16", F10세포를 이식한 C57BL, 대한침구의학회지, pp.2006, 23(1)[DOI]
- 임세영, "산삼약침이 Colon26-L5 암세포주를 이용한 간전이 모델의 항암 및 면역증진에 미치는 영향", 대한침구의학회지, 23(1), pp.121~134 (2006), 대한침구의학회
- 조병준, "Colon26-L5 대장암 세포를 이용한 간전이 모델에 산삼약침 처치가 혈 중 cytokine에 미치는 영향", Journal of Pharmacopuncture, 9(1), pp.127~137 (2006), 대한약침학회
- 민병일, "산양산삼 추출액의 항암효과 및 DOXORUBICIN에 의한 고환독성 방어효과", Journal of Pharmacopuncture, 10(1), pp.85~100 (2007), 대한약침학회
- Hwang JW., "Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-κB", Am J Chin Med, 40(1), pp.187~202 (2012)
- 홍민희, "산삼 배양근 추출물의 혈압강하 및 혈관이완 효과", Applied Biological Chemistry, 51(2), pp.102~107 (2008), 한국응용생명화학회
- 박원필, "산양산삼약침이 고지방식이에 의한 당뇨병 유발 흰쥐에 미치는 영향", Journal of Pharmacopuncture, 8(2), pp.97~108 (2005), 대한약침학회
- 김병우, "산양산삼 추출물이 지방세포의 분화에 미치는 영향", Journal of Pharmacopuncture, 10(3), pp.29~35 (2007), 대한약침학회
- 권선오, "산삼과 인삼 메탄올 추출물 아만성 복용의 Mice Tail Suspension Test에서의 항우울 효과에 대한 비교연구", 대한침구의학회지, 26(4), pp.99~106 (2009), 대한침구의학회
- Ki-Rok Kwon, "Clinical Observation of Multiple Metastatic Cancer Patient with Hepatocellular Carcinoma treated with Cultivated Wild Ginseng Herbal Acupuncture Therapy", 대한침구의학회지, 22(2), pp.211~221 (2005), 대한침구의학회
- 박봉기, "6개월간 산삼약침요법을 시행받은 ⅢB기 편평세포폐암 환자에 대한 증례보고", Journal of Pharmacopuncture, 10(3), pp.143~147 (2007), 대한약침학회
- 방선휘, "산삼약침 혈맥주입을 시행한 비소세포성폐암 환자 2례", Journal of Pharmacopuncture, 11(2), pp.13~20 (2008), 대한약침학회
- 권기록, "Case Series of Non-small Cell Lung Cancer Treated With Mountain Ginseng Pharmacopuncture", Journal of Acupuncture & Meridian Studies, 4(1), pp.61~68 (2011), 사단법인약침학회
- Jong-Hoon Lee, "Advanced Cancer Cases Treated With Cultivated Wild Ginseng Phamacopuncture", Journal of Acupuncture & Meridian Studies, 3(2), pp.119~124 (2010), 사단법인약침학회
- 이연희, "양방 항암치료와 병행하여 산삼약침과 봉약침 치료를 받은 전립선암 환자들의 PSA 수치 변화 관찰 보고", Journal of Pharmacopuncture, 14(4), pp.81~88 (2011), 대한약침학회
- 유영진, "산삼약침 치료를 시행한 근위축성 측삭 경화증 3례에 대한 임상보고", Journal of Pharmacopuncture, 13(4), pp.119~128 (2010), 대한약침학회